Posts tagged drug pricing
Bipartisanship in the 118th Congress

The first three months of the 118th Congress have had many moving pieces but a pace that largely lacked forward momentum. Despite the conventional wisdom on divided government that predicted gridlock and high-profile divisions this year, there are already a surprising number of bright spots where lawmakers are coming together to push forward legislation on a bipartisan basis. While it is certainly true that any of these could stall out, here is a sample of bipartisan proposals that could move this year.

Read More
COVID 3.5, 4.0, 5.0: Proposals for Future Stimulus Legislation

Plurus Strategies has been compiling a list of provisions, broken down by key industries, that could be a part of upcoming relief packages. As we continue to respond to the impacts of the pandemic, it’s important to have a good idea of what future bills could contain. The legislative situation is very fluid, and priorities and timelines continue to shift on a frequent basis. We are likely to see additional legislation that expands the role of government and allocates significantly more funding for the COVID-19 response.

Read More
2020 Outlook: Policymaking in an Election Year

Common knowledge may lead us to believe any hope of advancing policy in an election year is futile. Combine that trend with a divided Congress, a partisan atmosphere, and the imminent impeachment trial, and it’s easy to suggest 2020 will be a year for politics rather than policy. However, with a list of looming deadlines and the need to demonstrate the ability to not only investigate but also legislate, Congress is likely to have an active 12 months ahead.

Read More